The diastereoselective Pd(OAc) 2 -catalyzed, bidentate ligand-directed sp 3 C–H activation/arylation followed by ring opening of cyclopropanecarboxamides, which were assembled from cyclopropanecarbonyl chlorides and bidentate ligands (e.g., 8-aminoquinoline and 2-(methylthio)aniline), has been investigated. The treatment of various cyclopropanecarboxamides with excess amounts of aryl iodides in the presence of the Pd(OAc) 2 catalyst, AgOAc and AcOH directly afforded the corresponding multiple β-C–H arylated open-chain carboxamides ( anti β-acyloxy amides). This method has led to the construction of several anti β-acyloxy amides that possess vicinal stereocenters with a high degree of stereocontrol with the formation of a new C–O bond and three new C–C bonds. A plausible mechanism for the formation of multiple β-C–H arylated open-chain carboxamides from the Pd-catalyzed, bidentate ligand-directed β-C–H arylation and the ring opening of cyclopropanecarboxamides is proposed based on several control experiments. The observed diastereoselectivity and anti stereochemistry of the β-acyloxy amides were ascertained based on X-ray structural analysis of representative β-acyloxy amides.
No takes yet. Share an insight, caveat, or question.
Gopalakrishnan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: